The observer-blind, randomised controlled study to determine the safety and immunogenicity of "Covishield" on healthy Indian adults will begin at Bharati Vidyapeeth Medical College and Hospital in Pune.
from Times of India https://ift.tt/2Qt0Zt3
Find trending news, Grab latest news on trending and viral on social media, Breaking News, Latest News and Current News from FOXNews.com. Breaking news and video.
0 comments:
Post a Comment